# RETRACTION: miR‐664a‐3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer

## TL;DR

This retracted study claimed that miR-664a-3p promotes gastric cancer by targeting the Hippo pathway, but the results are no longer trusted due to duplicated figures.

## Contribution

The paper originally proposed miR-664a-3p as an oncogene in gastric cancer through Hippo pathway targeting, but this has been invalidated.

## Key findings

- The study was retracted due to duplicated figures in multiple sections.
- The authors attributed the duplication to negligence during data storage.
- The journal editors lost confidence in the study's results and conclusions.

## Abstract

RETRACTION: L. Wang, B. Li, L. Zhang, Q. Li, Z. He, X. Zhang, X. Huang, Z. Xu, Y. Xia, Q. Zhang, Q. Li, J. Xu, G. Sun, Z. Xu, “miR‐664a‐3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer,” Cell Proliferation 52, no. 3 (2019): e12567, https://doi.org/10.1111/cpr.12567.

The above article, published online on 18 March 2019, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor‐in‐Chief, Qi Zhou, and John Wiley and Sons Ltd. Following publication, concerns were raised by third parties regarding suspected duplication of figures 2c, 2d, 4g, 4h and 5a. The authors explained that the duplicates were a result of negligence during data storage. Due to the extent and nature of the mistakes made, the editors have lost confidence in the results and conclusions of this study.